Supreme Court Arguments – Banning Mifepristone

The case is the latest battle in the two year fight post-Roe.
Published: Mar. 26, 2024 at 5:08 PM CDT
Email This Link
Share on Pinterest
Share on LinkedIn

WASHINGTON (Gray DC) - One of the biggest reproductive rights cases since the fall of Roe hit the Supreme Court Tuesday.

At the center of it - an abortion pill used in two thirds of all pregnancy terminations.

The pro-life group of doctors at the center of this case are trying to make it harder for women to get access to a common abortion drug, Mifepristone.

They say women are coming into emergency rooms with abortion complications -

And it’s forcing them to make a moral choices.

Tuesday, Justices were skeptical of their narrative.

“FDA’s outsourcing of abortion drug harm to respondent doctors forces them to choose between helping a woman with a life threatening condition and violating their conscience,” argued lawyer Erin Hawley.

But the justices questioned whether this scene is common, or hypothetical.

“You need a person to be able to come in and meet the court’s regular standing requirements. So who’s your person?”asked Justice Kagan.

“Assuming we have a world in which they can actually lodge the objections that you say that they have.  My question is, isn’t that enough to remedy their issue? Do we have to also entertain you your argument that no one else in the world can have this drug or no one else in America should have this drug,” added Justice Brown-Jackson.

A decision is expected by the end of June.